Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer

dc.contributor.authorDiaz Riascos, Zamira Vanessa
dc.contributor.authorGinestà, Mireia M.
dc.contributor.authorFabregat Prous, Joan
dc.contributor.authorSerrano Piñol, M. Teresa
dc.contributor.authorBusquets Barenys, Juli
dc.contributor.authorBuscail, Louis
dc.contributor.authorCordelier, Pierre
dc.contributor.authorCapellá, G. (Gabriel)
dc.date.accessioned2020-10-19T08:09:17Z
dc.date.available2020-10-19T08:09:17Z
dc.date.issued2019-09-06
dc.date.updated2020-10-19T08:09:18Z
dc.description.abstractMicroRNAs from the miR-200 family are commonly associated with the inhibition of the metastatic potential of cancer cells, following inhibition of ZEB transcription factors expression and epithelial-to-mesenchymal transition. However, previous studies performed in pancreatic adenocarcinoma revealed a more complex picture challenging this canonical model. To gain better insights into the role of miR-200 family members in this disease, we analyzed the expression of miR-200a, miR- 200b, miR-200c, miR-141, miR-429, and miR-205, and ZEB1, ZEB2, and CDH1 in pancreatic tumors and matching normal adjacent parenchyma and patient-derived xenografts. We found that miR-200a, miR-429, and miR-205 are frequently overex- pressed in pancreatic tumors, whereas CDH1 is downregulated, and ZEB1 and ZEB2 levels remain unchanged. Furthermore, we measured a positive correlation between miR-200 family mem- bers and CDH1 expression, and a negative correlation between ZEB1 and miR-200c, miR-141, and miR-205 expression, respec- tively. Interestingly, we identified significant changes in expres- sion of epithelial-to-mesenchymal transition regulators and miR-200 members in patient-derived xenografts. Lastly, func- tional studies revealed that miR-141 and miR-429 inhibit the tumorigenic potential of pancreatic cancer cells. Taken together, this comprehensive analysis strongly suggests that miRNAs from the miR-200 family, and in particular miR-429, may act as a tu- mor suppressor gene in pancreatic cancer.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec703504
dc.identifier.issn2162-2531
dc.identifier.pmid31336236
dc.identifier.urihttps://hdl.handle.net/2445/171332
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.omtn.2019.06.015
dc.relation.ispartofMolecular Therapy-Nucleic Acids, 2019, vol. 17, p. 491-503
dc.relation.urihttps://doi.org/10.1016/j.omtn.2019.06.015
dc.rightscc-by-nc-nd (c) Diaz Riascos, Zamira Vanessa et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationCàncer de pàncrees
dc.subject.classificationMetàstasi
dc.subject.classificationMicro RNAs
dc.subject.otherPancreas cancer
dc.subject.otherMetastasis
dc.subject.otherMicroRNAs
dc.titleExpression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
703504.pdf
Mida:
3.29 MB
Format:
Adobe Portable Document Format